RE:Questiongrantoue wrote: in regards to the drug that the company took a write down on, was it a amco drug?????.
The 2 drugs that they took a write down were from the Covis purchase, so not amco. They were Plaquenil and Nilandron, and they said there was "unexpected" competition. The short people are expecting a huge write down on Donnatal next quarter and I have heard a couple of other
non-AMCo drugs mentioned